ClinicalTrials.Veeva

Menu

Refractive Change Induced by 2.8-mm Corneal Incision (CINPHA)

M

Madrid Health Service

Status

Completed

Conditions

Cataract
Astigmatism
Refractive Surgery

Treatments

Procedure: Temporal 2.8-mm corneal incision
Procedure: Nasal 2.8-mm corneal incision
Procedure: Superior 2.8-mm incision

Study type

Interventional

Funder types

Other

Identifiers

NCT00742950
CINPHACO

Details and patient eligibility

About

The investigators' purpose is to study the induced refractive change caused by different 2.8-mm corneal incision locations in phacoemulsification, because the investigators hypothesize that the effect may be different for nasal, temporal, and superior location, although they are considered astigmatism neutral.

Patients will be randomized to nasal or temporal incision, or assigned to superior incision, depending on preexisting astigmatism. Visual acuity, refraction, keratometry, Pentacam analysis, intraocular pressure, biomicroscopy, and funduscopy, will be carried out before and after phacoemulsification.

Outcome measures will be induced corneal refractive change (Fourier power vector analysis), ISV change, and visual acuity, at 6 months.

Enrollment

108 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Visual impairment for daily tasks caused by cataract
  • Age older than 50 years
  • Steep axis of corneal astigmatism at 90° ± 20° or 180° ± 20°
  • Ability to cooperate in the protocol procedures

Exclusion criteria

  • Age below 50
  • Inability to cooperate with measurements

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

108 participants in 3 patient groups

I
Active Comparator group
Description:
Nasal 2.8-mm corneal incision
Treatment:
Procedure: Nasal 2.8-mm corneal incision
II
Active Comparator group
Description:
Temporal 2.8-mm corneal incision
Treatment:
Procedure: Temporal 2.8-mm corneal incision
III
Active Comparator group
Description:
Superior 2.8-mm corneal incision
Treatment:
Procedure: Superior 2.8-mm incision

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems